| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/17/1993 | EP0527494A1 Compositon containing rhodacyanine dyes for treating cancer |
| 02/17/1993 | EP0527458A1 New 3,5-di-tert.-butyl-4-hydroxyphenyl derivatives, process for their preparation and pharmaceutical compounds |
| 02/17/1993 | EP0527364A2 Process for the preparation of succinylcholine halides |
| 02/17/1993 | EP0527298A1 Process for the preparation of pipazethate |
| 02/17/1993 | EP0527241A1 The use of Ascorbic acid for the preparation of medicaments for use in the genital region |
| 02/17/1993 | EP0527232A1 Thiazolidine-2,4-dione derivative, salt thereof, and production thereof |
| 02/17/1993 | EP0527189A1 Novel cc-1065 analogs |
| 02/17/1993 | EP0527181A1 Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase |
| 02/17/1993 | EP0527175A1 3-naphthyl-3-carboxyalkylthio or oxy substituted alkanoic acid leukotriene antagonists |
| 02/17/1993 | CN1069070A Preparation method for r-sub anacsthesia and biological products composed mainly of it |
| 02/17/1993 | CN1069028A Asymmetric synthesis of taxol side chain |
| 02/17/1993 | CN1069025A Aryl, amide, imide, and carbamate pyridine antagonists of platelet activating factor |
| 02/17/1993 | CN1069024A Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for preparation thereof |
| 02/17/1993 | CN1069023A 4-(2-hydroxy-2-phenylethylamino) ethoxy) phenylacetic acid derivatives used in therapy obesity and related state |
| 02/17/1993 | CN1069022A 4-(2-(2-hydroxy-2-phenylethylamino) ethoxy) phenylacetic acid derivatives used in therapy obesity and related state |
| 02/17/1993 | CN1019911C Benzoxazine derivative and processes for preparing same |
| 02/17/1993 | CA2076204A1 Hiv protease inhibitors with n-terminal polyether substituents |
| 02/17/1993 | CA2076192A1 Thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 02/17/1993 | CA2076149A1 Potentiation of antitussive effect of dextromethorphan |
| 02/17/1993 | CA2075666A1 Hiv protease inhibitors useful for the treatment of aids |
| 02/17/1993 | CA2067265A1 17.beta.-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5.alpha.-reductase inhibitors |
| 02/16/1993 | US5187286 Antiinflammatory agents, antiallergens |
| 02/16/1993 | US5187277 DL-3-[4-[4-(2-pyridyl)-1-piperazinyl]-butyl]-1,8,8-trimethyl-3-azabicyclo[(3]octane-2,4-dione having psychotropic and antiemetic effect |
| 02/16/1993 | US5187195 Anthraquinone derivatives and preparation thereof |
| 02/16/1993 | US5187193 Method for stimulating transplanted bone marrow cells |
| 02/16/1993 | US5187190 Treatment of obesity |
| 02/16/1993 | US5187180 (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
| 02/16/1993 | US5187179 Angiotensin II antagonists incorporating a substituted imidazo [1,2-b][1,2,4]triazole |
| 02/16/1993 | US5187173 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 02/16/1993 | US5187171 Use of a glycine b partial agonist as an antipsychotic |
| 02/16/1993 | US5187169 Method for treatment of neurodegenerative diseases |
| 02/16/1993 | US5187168 Substituted quinazolines as angiotensin II antagonists |
| 02/16/1993 | US5187164 Psychological disorders, antiemetics |
| 02/16/1993 | US5187162 Methods of treating neurodegenerative conditions |
| 02/16/1993 | US5187160 7-(2-(aminothiazol-4-yl)-2-alkoxyiminoacetamido),3-(2 -hydroxyalkylpyrazol-2-ium-2-yl)methyl)-3-cephem carboxylate; microbiocides |
| 02/16/1993 | US5187159 Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole |
| 02/16/1993 | US5186942 Nicardipine therapy |
| 02/16/1993 | US5186940 Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
| 02/16/1993 | US5186939 Laminated composite for transdermal administration of fentanyl |
| 02/16/1993 | US5186925 Nitroglycerin pump spray |
| 02/16/1993 | US5186923 Enhancement of cellular accumulation of lipophilic cationic organometallic compounds by reduction of intramembrane potential |
| 02/16/1993 | US5186817 Converting the hydrocarbon feed to a water in oil emulsion and solvent extracting |
| 02/16/1993 | CA2076191A1 Therapeutic compounds |
| 02/16/1993 | CA2076168A1 Therapeutic agents |
| 02/16/1993 | CA2076146A1 Piperidine derivatives |
| 02/16/1993 | CA2076057A1 N-acyl-n-heterocyclylalkylamino acids, processes, compositions and use |
| 02/16/1993 | CA1313725C Crystalline l-carnosine zinc complex and production thereof |
| 02/16/1993 | CA1313674C Use of 1,3-butanediol acetoacetate in parenteral and enteral nutrition |
| 02/16/1993 | CA1313667C Indole alkaloid composition and their methods of use |
| 02/16/1993 | CA1313662C Retinoic esters of macrolids, process for their preparation, and cosmetical and pharmaceutical compositions containing them |
| 02/16/1993 | CA1313660C Insaturated cycloaliphatic esters of macrolidic and lincosamidic antibiotics, process for their preparation and pharmaceutical and cosmetical compositions containing them |
| 02/16/1993 | CA1313659C Polyaromatic esters of macrolidic and lincosamidic antibiotics, process for their preparation and pharmaceutical and cosmetical compositions containing them |
| 02/16/1993 | CA1313658C Aromatic esters of macrolidic and lincosamidic antibiotics, process for their preparation and pharmaceutical and cosmetical compositions containing them |
| 02/16/1993 | CA1313657C Bioaromatic esters of macrolidic and lincosamidic antibiotics, process for their preparation and pharmaceutical and cosmetical compositions containing them |
| 02/16/1993 | CA1313656C Polycyclic aromatic esters of macrolidic and lincosamidic antibiotics, process for their preparation, and pharmaceutical and cosmetical compositions containing them |
| 02/16/1993 | CA1313655C Cis-platinum complexes, a process for the preparation thereof, and pharmaceuticals containing these compounds |
| 02/16/1993 | CA1313654C Cephalosporins containing a substituted vinyl radical in 3; process for preparing the same; their use as drugs; compositions containing them and new intermediates produced |
| 02/16/1993 | CA1313653C 7-substituted 19-nor steroids; process for preparing them; their use as drugs and pharmaceutical compositions containing them |
| 02/16/1993 | CA1313623C Transdermal estrogen/progestin dosage unit, system and process |
| 02/16/1993 | CA1313622C Pharmaceutical composition containing 17.beta.oestradiol and desogestr el |
| 02/14/1993 | CA2075652A1 Quinoline and azaquinoline angiotensin ii antagonists incorporating a substituted benzyl element |
| 02/14/1993 | CA2072735A1 Process for the preparation of succinylcholine halides |
| 02/13/1993 | CA2075671A1 Treatment of congestive heart failure |
| 02/13/1993 | CA2075356A1 Pharmaceutical spheroid formulation |
| 02/13/1993 | CA2075355A1 Pharmaceutical combination formulation |
| 02/11/1993 | DE4126543A1 Drug compsn. contg. 3(5)-(hydroxyaryl)-pyrazole derivs. - for inhibition of lipoxygenase and cyclo:oxygenase in treatment of asthma, allergy, inflammation, skin disorders, myocardial infarction etc. |
| 02/11/1993 | CA2075547A1 Trifluoromethyl-containing pseudopeptides |
| 02/10/1993 | WO1993002684A1 β-GLUCURONIDASE INHIBITOR |
| 02/10/1993 | EP0527117A1 Substituted cyclopropylamino-1,3,5-triazines |
| 02/10/1993 | EP0527112A2 Butyrylamides as pesticides |
| 02/10/1993 | EP0527101A1 New pharmaceutical compositions derived from acid fraction of the lipid extracts of sabal serrulata, with antagonistic adrenergic effect and method to obtain these compositions |
| 02/10/1993 | EP0527081A1 Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use |
| 02/10/1993 | EP0527079A1 N-(isoquinolein-5-yl)-sulfonyl azacycloalkanes, their process of preparation and pharmaceutical compositions containing them |
| 02/10/1993 | EP0527069A1 Derivatives of pyrrolidine and thiazolidine, their preparation, and pharmaceutical compositions containing them |
| 02/10/1993 | EP0527042A2 3-deoxy-mannosamine derivatives and process for their preparation |
| 02/10/1993 | EP0526936A2 Cholesterol-lowering agents |
| 02/10/1993 | EP0526935A1 New microorganism for producing C-31 desmethyl FR-900520 cyclic hemiketal |
| 02/10/1993 | EP0526934A1 New C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent |
| 02/10/1993 | EP0526906A1 Process for producing 3-deacylated derivatives of a 16-membered macrolide antibiotic, microorganism to be used therefor and novel macrolide antibiotic |
| 02/10/1993 | EP0526877A2 Peptide aldehydes as antithrombotic agents |
| 02/10/1993 | EP0526866A1 The use of adenosine compounds for the preparation in the treatment of ischaemia |
| 02/10/1993 | EP0526865A1 Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery |
| 02/10/1993 | EP0526840A1 Condensed naphthyridine derivatives |
| 02/10/1993 | EP0526756A1 Composition for revitalizing scar tissue |
| 02/10/1993 | EP0526754A1 Aqueous solutions and their use |
| 02/10/1993 | EP0526708A1 Sulfonamide, preparation and use thereof as medicine and intermediate |
| 02/10/1993 | EP0526695A1 Stabilized PVP-I solutions |
| 02/10/1993 | EP0526658A1 Thiazolidine-2,4-dione derivative, salt thereof, and production of the same |
| 02/10/1993 | EP0526642A1 Triterpene derivative |
| 02/10/1993 | EP0526638A1 Remedy for obstructive pulmonary disease |
| 02/10/1993 | EP0526608A1 Therapeutic agents for the treatment of multidrug resistance to cancers. |
| 02/10/1993 | EP0526578A1 Composition and method for topical treatment of damaged or diseased tissue |
| 02/10/1993 | EP0526566A1 Treatment of erectile dysfunction |
| 02/10/1993 | EP0526545A1 Isoquinoline amides and esters as 5 ht3 receptor antagonists |
| 02/10/1993 | EP0526543A1 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents |
| 02/10/1993 | EP0526540A1 Use of 5-ht 4? receptor antagonists in the treatment of arrythmias and stroke |
| 02/10/1993 | EP0526529A1 An improved process for the preparation of substituted indolone derivatives. |
| 02/10/1993 | EP0526495A1 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use |
| 02/10/1993 | EP0445156B1 Agents for treating chronic inflammatory diseases of the intestines |
| 02/10/1993 | EP0409881B1 N-heterocyclic propylidene-1,1-bisphosphonic acids, their production and a pharmaceutical composition |